SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemo Pharma Labs - Quaterly Results

28 Jul 2022 Evaluate
The revenue for the June 2022 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Net Loss for the quarter ended June 2022 is Rs. -5.01 millions as compared to Net Profit of Rs. 0.31 millions of corresponding quarter ended June 2021Operating profit Margin for the quarter ended June 2022 slipped to -4.98% as compared to 0.31% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income -3.85 1.09 -453.21 -3.85 1.09 -453.21 7.89 6.68 18.11
PBIDT -4.98 0.31 -1706.45 -4.98 0.31 -1706.45 3.84 3.35 14.63
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -4.98 0.31 -1706.45 -4.98 0.31 -1706.45 3.84 3.35 14.63
Depreciation 0.03 0.00 0.00 0.03 0.00 0.00 0.19 0.24 -20.83
PBT -5.01 0.31 -1716.13 -5.01 0.31 -1716.13 3.65 3.11 17.36
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -1.96 0.60 -426.67
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.30 0.00 0.00
PAT -5.01 0.31 -1716.13 -5.01 0.31 -1716.13 5.61 2.51 123.51
Equity 15.00 15.00 0.00 15.00 15.00 0.00 15.00 15.00 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Starsource Multitrad Share Price

110.70 -5.80 (-4.98%)
20-Apr-2026 13:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.50
Dr. Reddys Lab 1234.90
Cipla 1232.60
Zydus Lifesciences 936.50
Lupin 2332.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×